Adnexus, A Bristol-Myers Squibb R&D Company
3 clinical trials · Sponsor
◉ Watch Adnexus, A Bristol-Myers Squibb R&D Company
| Record | Firm | Date |
|---|---|---|
| CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme (NCT00768911) | Adnexus, A Bristol-Myers Squibb R&D Company | 2008-10-01 |
| CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan (NCT00562419) | Adnexus, A Bristol-Myers Squibb R&D Company | 2007-10-01 |
| CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NCT00374179) | Adnexus, A Bristol-Myers Squibb R&D Company | 2006-08-01 |
Track Adnexus, A Bristol-Myers Squibb R&D Company automatically
Every clearance here is in the API, with alerts when new ones post.